PERT CONSORTIUM
LIVE

Serial Number

99887491

Owner

National PERT Consortium Inc.

Attorney

Alex P Garens

Filing Date

Jun 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

PERT CONSORTIUM Trademark

Serial Number: 99887491

PERT CONSORTIUM is a trademark filed by National PERT Consortium Inc. on June 16, 2026. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

National PERT Consortium Inc. (13 trademarks)

PO Box 108
Brookline, NH 03033

Entity Type: 99

Trademark Details

Filing Date

June 16, 2026

Registration Date

Not Registered

Goods & Services

Medical education services, namely, providing classes, seminars, training, and workshops for physicians and other health care professionals in the field of prevention and treatment of pulmonary embolism; Educational and entertainment services, namely, organizing educational events in the nature of conducting live and online medical conferences in the field of the prevention and treatment of pulmonary embolism; Providing online non-downloadable educational resources in the nature of articles, publications, videos, webinars, and training materials in the field of pulmonary embolism care

Association services, namely, promoting the adoption and acceptance of common industry standards in the field of pulmonary embolism; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of pulmonary embolism; Promoting public and professional awareness of pulmonary embolism recognition, prevention, treatment, care standards, and patient outcomes; Business networking services for stakeholders in the field of pulmonary embolism care

Developing standards of care for physicians and other health care professionals treating patients with pulmonary embolism; Providing medical information in the field of pulmonary embolism recognition, prevention, diagnosis, treatment, care pathways, quality improvement, and patient outcomes; Providing healthcare information to healthcare professionals, patients, and stakeholders in the field of pulmonary embolism care; Providing information regarding evidence-based clinical practices and care standards in the field of pulmonary embolism care

Medical research in the field of pulmonary embolism; Scientific laboratory research in the field of pulmonary embolism; Testing, analysis and evaluation of service providers to determine conformity with established accreditation standards

Filing History

APPLICATION FILING RECEIPT MAILED
Jun 16, 2026 MAFR
NEW APPLICATION ENTERED
Jun 16, 2026 NWAP